CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 84.75K shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.47M shares, a 184.24% increase from fiscal 2024.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 518.27K shares, a 82.14% increase from fiscal 2023.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 284.54K shares, a 95.45% decline from fiscal 2022.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 6.25M shares, a 211.79% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | 84.75K shares derived: sum of 3 quarters · filed 2026-08-14 | 84.75K shares derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 84.75K shares derived: sum of 2 quarters · filed 2026-05-13 | 84.75K shares derived: sum of 3 quarters · filed 2026-05-13 | 986.75K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 84.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 84.75K shares derived: sum of 2 quarters · filed 2026-03-24 | 986.75K shares derived: sum of 3 quarters · filed 2026-03-24 | 1.47M shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 902.00K shares derived: sum of 2 quarters · filed 2025-11-06 | 1.39M shares 10-Q · filed 2025-11-06 | 1.39M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 902.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 1.39M shares 10-Q · filed 2025-08-05 | 1.39M shares derived: sum of 3 quarters · filed 2025-08-05 | 1.41M shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 486.40K shares 10-Q · filed 2025-05-06 | 486.40K shares derived: sum of 2 quarters · filed 2025-05-06 | 511.40K shares derived: sum of 3 quarters · filed 2025-05-06 | 720.90K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 25.00K shares derived: sum of 2 quarters · filed 2025-03-31 | 234.50K shares derived: sum of 3 quarters · filed 2025-03-31 | 518.27K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 234.50K shares derived: sum of 2 quarters · filed 2024-11-14 | 518.27K shares 10-Q · filed 2024-11-14 | 529.61K shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 209.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | 493.27K shares 10-Q · filed 2024-08-01 | 504.61K shares derived: sum of 3 quarters · filed 2024-08-01 | -4.69M shares derived: sum of 4 quarters · filed 2024-08-01 |
| 2024-03-31 | 283.77K shares 10-Q · filed 2024-05-07 | 295.11K shares derived: sum of 2 quarters · filed 2024-05-07 | -4.90M shares derived: sum of 3 quarters · filed 2024-05-07 | -4.40M shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 11.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | -5.18M shares derived: sum of 2 quarters · filed 2024-02-08 | -4.68M shares derived: sum of 3 quarters · filed 2024-02-08 | 284.54K shares 10-K · filed 2024-02-08 |
| 2023-09-30 | -5.19M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -4.69M shares derived: sum of 2 quarters · filed 2023-11-02 | 273.20K shares 10-Q · filed 2023-11-02 | 419.85K shares derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | 500.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 5.46M shares 10-Q · filed 2023-08-03 | 5.61M shares derived: sum of 3 quarters · filed 2023-08-03 | 7.02M shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 4.96M shares 10-Q · filed 2023-05-04 | 5.11M shares derived: sum of 2 quarters · filed 2023-05-04 | 6.52M shares derived: sum of 3 quarters · filed 2023-05-04 | 6.91M shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 146.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | 1.56M shares derived: sum of 2 quarters · filed 2023-03-13 | 1.94M shares derived: sum of 3 quarters · filed 2023-03-13 | 6.25M shares 10-K · filed 2023-03-13 |
| 2022-09-30 | 1.41M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 1.79M shares derived: sum of 2 quarters · filed 2022-11-09 | 6.11M shares 10-Q · filed 2022-11-09 | 6.28M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 380.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 4.69M shares 10-Q · filed 2022-08-04 | 4.87M shares derived: sum of 3 quarters · filed 2022-08-04 | 5.13M shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 4.31M shares 10-Q · filed 2022-05-05 | 4.49M shares derived: sum of 2 quarters · filed 2022-05-05 | 4.75M shares derived: sum of 3 quarters · filed 2022-05-05 | 4.92M shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 174.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 435.80K shares derived: sum of 2 quarters · filed 2022-02-24 | 603.10K shares derived: sum of 3 quarters · filed 2022-02-24 | 2.01M shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 261.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 428.85K shares derived: sum of 2 quarters · filed 2021-11-09 | 1.83M shares 10-Q · filed 2021-11-09 | 1.83M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 167.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 1.57M shares 10-Q · filed 2021-08-03 | 1.57M shares derived: sum of 3 quarters · filed 2021-08-03 | 1.57M shares derived: sum of 4 quarters · filed 2021-08-03 |
| 2021-03-31 | 1.40M shares 10-Q · filed 2021-05-12 | 1.40M shares derived: sum of 2 quarters · filed 2021-05-12 | 1.40M shares derived: sum of 3 quarters · filed 2021-05-12 | 1.51M shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-16 | 110.00K shares derived: sum of 3 quarters · filed 2021-03-16 | 3.37M shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 110.00K shares derived: sum of 2 quarters · filed 2020-11-10 | 3.37M shares 10-Q · filed 2020-11-10 | 3.53M shares derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | 110.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 3.37M shares 10-Q · filed 2020-08-04 | 3.53M shares derived: sum of 3 quarters · filed 2020-08-04 | 3.89M shares derived: sum of 4 quarters · filed 2020-08-04 |
| 2020-03-31 | 3.26M shares 10-Q · filed 2020-05-12 | 3.42M shares derived: sum of 2 quarters · filed 2020-05-12 | 3.78M shares derived: sum of 3 quarters · filed 2020-05-12 | 5.43M shares derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-12-31 | 157.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 520.50K shares derived: sum of 2 quarters · filed 2020-03-19 | 2.17M shares derived: sum of 3 quarters · filed 2020-03-19 | 4.03M shares 10-K · filed 2020-03-19 |
| 2019-09-30 | 363.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 2.02M shares derived: sum of 2 quarters · filed 2019-11-05 | 3.88M shares 10-Q · filed 2019-11-05 | 3.97M shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2019-06-30 | 1.65M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 3.51M shares 10-Q · filed 2019-08-09 | 3.60M shares derived: sum of 3 quarters · filed 2019-08-09 | 4.36M shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 1.86M shares 10-Q · filed 2019-05-14 | 1.95M shares derived: sum of 2 quarters · filed 2019-05-14 | 2.71M shares derived: sum of 3 quarters · filed 2019-05-14 | 1.78M shares derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | 90.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 852.00K shares derived: sum of 2 quarters · filed 2019-03-26 | -80.40K shares derived: sum of 3 quarters · filed 2019-03-26 | 2.07M shares 10-K · filed 2019-03-26 |
| 2018-09-30 | 762.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -170.40K shares derived: sum of 2 quarters · filed 2018-11-01 | 1.98M shares 10-Q · filed 2018-11-01 | 1.98M shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-30 | -932.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 1.22M shares 10-Q · filed 2018-08-02 | 1.22M shares derived: sum of 3 quarters · filed 2018-08-02 | 1.42M shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 2.15M shares 10-Q · filed 2018-05-03 | 2.15M shares derived: sum of 2 quarters · filed 2018-05-03 | 2.35M shares derived: sum of 3 quarters · filed 2018-05-03 | 2.61M shares derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 200.00K shares derived: sum of 2 quarters · filed 2018-03-08 | 459.00K shares derived: sum of 3 quarters · filed 2018-03-08 | 6.11M shares 10-K · filed 2018-03-08 |
| 2017-09-30 | 200.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 459.00K shares derived: sum of 2 quarters · filed 2017-11-07 | 6.11M shares 10-Q · filed 2017-11-07 | |
| 2017-06-30 | 259.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 5.91M shares 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | 5.65M shares 10-Q · filed 2017-05-04 | |||
| 2016-12-31 | 5.34M shares 10-K · filed 2017-03-09 | |||
| 2015-12-31 | 3.23M shares 10-K · filed 2016-02-29 | |||
| 2014-12-31 | 2.28M shares 10-K · filed 2015-02-24 | |||
| 2013-12-31 | 2.86M shares 10-K · filed 2014-03-13 | |||
| 2012-12-31 | 1.65M shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |